LeMaitre Vascular
LMAT
165 hedge funds and large institutions have $623M invested in LeMaitre Vascular in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 47 reducing their positions, and 11 closing their positions.
182% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 11
32% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 47
15% more capital invested
Capital invested by funds: $541M → $623M (+$82.1M)
14% more funds holding
Funds holding: 145 → 165 (+20)
6.96% more ownership
Funds ownership: 79.76% → 86.72% (+7%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
LMAT Hedge Fund Activity: Q4 2019 in Review
165 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q4 2019, worth a combined $623M — up 15% from $541M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new LMAT positions and 11 closed out — a net gain of 20 holders — while 62 added to existing stakes and 47 trimmed.
The largest buyer was Principal Financial Group, adding an estimated $13.8M. The largest seller was Dimensional Fund Advisors, cutting an estimated $963K.
- 165 institutional investors held LeMaitre Vascular (LMAT) as of Q4 2019, up from 145 in Q3 2019.
- Funds reported $623M of LeMaitre Vascular stock for Q4 2019, up 15% quarter-over-quarter.
- 31 funds opened new LeMaitre Vascular positions in Q4 2019 and 11 closed out, a net change of +20 holders.
- The largest LeMaitre Vascular buyer in Q4 2019 was Principal Financial Group, an estimated $13.8M added.
- The largest LeMaitre Vascular seller in Q4 2019 was Dimensional Fund Advisors, an estimated $963K sold.
Based on aggregated 13F filings for Q4 2019.